European Directorate for the Quality of Medicines & Health Care (EDQM) has issued a Certificate of Suitability for Company's API product "Quetiapine Fumarate" on 4th March 2025.
This certification will enable the Company to export Quetiapine Fumarate to European and other countries that accept CEPs. Quetiapine Fumarate is an antipsychotic drug which is widely used to treat various mental health disorders.
Shares of IOL Chemicals and Pharmaceuticals Limited was last trading in BSE at Rs. 327.70 as compared to the previous close of Rs. 315.40. The total number of shares traded during the day was 13212 in over 770 trades.
The stock hit an intraday high of Rs. 334.70 and intraday low of 315.70. The net turnover during the day was Rs. 4336869.00. |
